Overview

Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction

Status:
Completed

Trial end date:
2015-07-01

Target enrollment:

Participant gender:

Summary

A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 'URSA SOFT CAP. (UDCA-003)' in fatigue patients with liver dysfunction

Phase:

Phase 4

Details

Lead Sponsor:

Daewoong Pharmaceutical Co. LTD.

Treatments:

Riboflavin
Thiamine
Ursodeoxycholic Acid